Please assess the completion status of the following clinical trial:

Trial Title: Near Infrared Spectroscopy (NIRS) as Transfusion Indicator in Neurocritical Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Severe traumatic brain injury (Glasgow coma scale \< 9), subarachnoid hemorrhage (Hunt and Hess scale ≥ 3) or intracranial hemorrhage~* Moderate anemia. Hemoglobin levels \> 7 g/dL and \< 10 g/dL~* Hemodynamical stability (mean arterial pressure \> 75 mm Hg)~* Respiratory stability (PaO2 / FiO2 ratio \> 220)~* Expected length of ICU stay \> 3 days~Exclusion Criteria:~* Patient's relatives' refusal to patient's inclusion in the study~* Active bleeding~* Ongoing need for blood products~* Patients necessitating ongoing resuscitation~* End-stage in which death is imminent~* Antecedents of angina or myocardial infarction (poor cardiopulmonary reserve)~* Deficient signal of rSO2 impeding its proper valuation

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- RBCT based on rSO2 value (Type: EXPERIMENTAL): Intervention: In the rSO2 - strategy group, patients will be transfused to attain a post-transfusion rSO2 values higher than 60%.
- RBCT based on hemoglobin level value (Type: ACTIVE_COMPARATOR): Intervention: In the hemoglobin - strategy group, patients will be transfused to reach post-transfusion hemoglobin levels between 8.5 g/dL and 10 g/dL.

Based on this trial design, predict the completion outcome and termination type (if applicable).